In line with this, a recent study showed that IL-1β supports clonal expansion of Jak2 mutated HSPCs in MPN mice and deletion of IL-1β in these mice reduces disease burden (Rai et al., 2019). This evidence concerns the gene IL1B and myeloproliferative disorder.